B. Weyhenmeyer

Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family

G. Peters, G. J. Peters, F. Kruyt, 2013, Cell Death and Differentiation.

Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis

A. Letai, D. Kögel, J. Prehn, 2013, Apoptosis.

Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach

V. Seifert, M. Rehm, D. Kögel, 2013, Cell Death and Disease.

Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer.

J. Prehn, B. Murphy, Á. Murphy, 2012, Experimental oncology.

Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide

M. Rehm, M. Würstle, B. Murphy, 2016, Oncotarget.